# Clinical Trial on the Reduction of Methicillin Resistant Staphylococcus Aureus (MRSA)

> **NCT00790608** · PHASE2 · TERMINATED · sponsor: **Nitric BioTherapeutics, Inc** · enrollment: 8 (actual)

## Conditions studied

- Skin Ulcers
- Methicillin-resistant Staphylococcus Aureus Infection

## Interventions

- **DRUG:** Nitric Oxide

## Key facts

- **NCT ID:** NCT00790608
- **Lead sponsor:** Nitric BioTherapeutics, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-01
- **Primary completion:** 2009-05
- **Final completion:** 2011-08
- **Target enrollment:** 8 (ACTUAL)
- **Why stopped:** Limited recruitment
- **Last updated:** 2011-11-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00790608

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00790608, "Clinical Trial on the Reduction of Methicillin Resistant Staphylococcus Aureus (MRSA)". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00790608. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*